Literature DB >> 2138462

Characterization of a chemotactic defect in patients with Kartagener syndrome.

R J Walter1, J R Danielson, H M Reyes.   

Abstract

Kartagener syndrome (KS) is an autosomally inherited recessive condition characterized by situs inversus, bronchiectasis, and chronic sinusitis. Ciliary dynein, the mechanochemical force generator in ciliary movement, is deficient in patients with KS. We examined blood samples from two patients and tissue biopsy specimens from five patients and found: (1) no significant defect in neutrophil or monocyte chemotaxis in response to formylpeptide chemoattractant; (2) no alterations in centriolar structure, but significantly more centriole-associated microtubules in KS neutrophils and monocytes than in control leukocytes; and (3) a marked reduction in KS fibroblast chemotaxis in response to fibronectin compared with control fibroblasts. The significance of these cellular defects in KS is described.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138462     DOI: 10.1001/archotol.1990.01870040087020

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

Review 1.  Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.

Authors:  Maaike Cockx; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

2.  Ccdc103 promotes myeloid cell proliferation and migration independent of motile cilia.

Authors:  Lauren G Falkenberg; Sarah A Beckman; Padmapriyadarshini Ravisankar; Tracy E Dohn; Joshua S Waxman
Journal:  Dis Model Mech       Date:  2021-05-24       Impact factor: 5.758

3.  The Antimicrobial Activity of Peripheral Blood Neutrophils Is Altered in Patients with Primary Ciliary Dyskinesia.

Authors:  Maaike Cockx; Marfa Blanter; Mieke Gouwy; Pieter Ruytinx; Sara Abouelasrar Salama; Sofie Knoops; Noëmie Pörtner; Lotte Vanbrabant; Natalie Lorent; Mieke Boon; Sofie Struyf
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.